Australian Pharmaceutical Industries Ltd
ASX:API
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Australian Pharmaceutical Industries Ltd
ASX:API
|
AU |
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
|
C
|
ChemoCentryx Inc
F:2CX
|
US |
|
Osisko Development Corp
XTSX:ODV
|
CA |
|
B
|
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
|
CA |
|
V
|
Voronoi Inc
KOSDAQ:310210
|
KR |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of API.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
API Competitors Multiples
Australian Pharmaceutical Industries Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Australian Pharmaceutical Industries Ltd
ASX:API
|
753.8m AUD | 0.2 | 547.4 | 41.1 | 41.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
105.8B USD | 0.3 | 24.4 | 17.1 | 19.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.1B USD | 0.2 | 38.2 | 13.5 | 17.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.8B USD | 0.2 | 37.4 | 13.3 | 16.8 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.8B USD | 0.2 | 29.3 | 14.2 | 18.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.1B AUD | 2.6 | 33.1 | 24.6 | 24.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61B CNY | 0.2 | 10.8 | 14.8 | 14.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.3B USD | 0.6 | 21 | 10.3 | 14.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 1.4 | 15.9 | 12.2 | 12.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63B HKD | 0.1 | 7.9 | 0.6 | 0.8 |